Osaic Holdings’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Buy
2,709
+1,676
+162% +$62.5K ﹤0.01% 4824
2026
Q1
$41.6K Buy
1,033
+89
+9% +$3.83K ﹤0.01% 5349
2025
Q4
$47.8K Buy
944
+615
+187% +$21.8K ﹤0.01% 5264
2025
Q3
$9.23K Buy
329
+65
+25% +$1.5K ﹤0.01% 6415
2025
Q2
$6.22K Buy
+264
New +$5.94K ﹤0.01% 6417
2025
Q1
Sell
-79
Closed -$3.34K 7721
2024
Q4
$3.34K Buy
79
+3
+4% +$133 ﹤0.01% 6394
2024
Q3
$3.36K Hold
76
﹤0.01% 6390
2024
Q2
$2.75K Buy
+76
New +$3.02K ﹤0.01% 6473

Other funds holding VERA

Osaic Holdings's VERA Position: Q2 2026 in Review

Osaic Holdings increased its Vera Therapeutics (VERA) stake by 162% in Q2 2026, buying an estimated $62.5K and bringing the position to 2,709 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #4824.

Osaic Holdings first reported a position in VERA in Q2 2024 and has held it in 8 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Osaic Holdings held 2,709 shares of Vera Therapeutics worth $116K as of Q2 2026.
  • Osaic Holdings bought 1,676 Vera Therapeutics shares in Q2 2026, an estimated $62.5K.
  • Vera Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4824 holding.
  • Osaic Holdings first reported a position in Vera Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.